NSF/FDA SIR: Morphologically Complex Tissue-Mimicking Phantoms for Evaluating Tissue Scattering Artifacts in Photoacoustic Imaging

NSF/FDA SIR:形态复杂的组织模拟体模,用于评估光声成像中的组织散射伪影

基本信息

  • 批准号:
    1937674
  • 负责人:
  • 金额:
    $ 20万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-01 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

NON-TECHNICAL ABSTRACT:Ultrasound is a powerful tool to image diseases including cancer, orthopedic disorders, and heart function. One limitation of ultrasound is that it suffers from low contrast (contrast is the difference in signal intensity between the region of interest and the background tissue). Therefore, there is a large body of research into a special kind of ultrasound known as photoacoustic imaging. Photoacoustic imaging uses light to generate sound only in the area of interest-this increases the contrast. Unfortunately, photoacoustic ultrasound is not yet approved for widespread use in people. This might be partially due to a lack of devices and methods to validate and standardize the novel imaging equipment needed for photoacoustic imaging. Therefore, this work will create specialized plastic objects with known optical and acoustic properties suitable for calibrating and standardizing photoacoustic imaging equipment. This proposal combines expertise from academia and the Food and Drug Administration to identify materials that have optical and acoustic properties similar to human tissue. We will create test objects and methods that will be useful to instrument manufacturers and physicians. The resulting test objects will improve knowledge of how to best create photoacoustic imaging instrumentation and might also streamline regulatory approval of this equipment. In turn, this will increase patient access to this important imaging technique to ultimately advance the national health and quality of life. TECHNICAL ABSTRACT:Photoacoustic imaging provides deep tissue imaging similar to ultrasound but with enhanced optical contrast and additional functional and molecular imaging capabilities. However, no standardized performance test methods or phantoms exist for photoacoustic imaging system evaluation unlike mature techniques such as computed tomography. The fundamental limitation-and scientific problem to be studied here is a lack of materials to simultaneously simulate tissue properties over a broad range of optical wavelengths and acoustic frequencies. This leaves investigators, instrument manufacturers, and regulatory agencies without clear strategies to evaluate device safety and effectiveness. This project with the Food and Drug Administration (FDA) builds stable, biologically relevant imaging phantoms with well-characterized optical absorption/scattering coefficients, acoustic impedance, etc. that broadly simulate tissue over a wide range of optical wavelengths and acoustic frequencies. Objective 1 of this research develops phantoms with biologically relevant heterogeneous morphologies and light scattering artifacts during photoacoustic imaging. Phantom material optical and acoustic properties are rigorously characterized using spectrophotometry and acoustic pulse-transmission equipment available at FDA. The imaging phantoms contain multiple layers of background material with different optical and acoustic properties designed to mimic natural tissue (e.g. breast fat and glandular tissue or muscle and fat layers) as well as target inclusions. The inclusions have regular shapes (cylinders, spheres) of varying sizes as well as image-derived, tortuous vessel-mimicking structures. Objective 2 uses these phantoms to establish test methods that evaluate the impact of fluence artifacts on device performance in three different imaging systems. System image uniformity and out-of-plane sensitivity are evaluated during mechanical scanning of probes over realistic vessel-mimicking inclusions known to produce volumetric images. Sets of phantoms containing inclusions mimicking blood absorption at several oxygen saturation levels-but with different background optical properties and layer morphologies-serve in parametric studies of device performance in the face of spectral coloring artifacts. The measurement accuracy of our three photoacoustic imaging systems is quantified to determine device robustness using various fluence correction methods (diffusion theory, Monte Carlo simulations). The outcome is a well-validated tissue-mimicking phantom to support device developers and inform regulatory decision-making including use as a potential Food and Drug Administration Medical Device Development Tool.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
非技术摘要:超声是一种强大的工具,可以对包括癌症、骨科疾病和心脏功能在内的疾病进行成像。超声波的一个局限性是它具有低对比度(对比度是感兴趣区域和背景组织之间的信号强度差异)。因此,有大量的研究进入一种特殊的超声称为光声成像。光声成像利用光只在感兴趣的区域产生声音,这增加了对比度。不幸的是,光声超声尚未被批准在人类中广泛使用。这可能部分是由于缺乏设备和方法来验证和标准化光声成像所需的新型成像设备。因此,这项工作将创建具有已知光学和声学特性的专用塑料物体,适用于校准和标准化光声成像设备。该提案结合了学术界和食品和药物管理局的专业知识,以确定具有与人体组织相似的光学和声学特性的材料。我们将创建对仪器制造商和医生有用的测试对象和方法。由此产生的测试对象将提高如何最好地创建光声成像仪器的知识,也可能简化该设备的监管批准。反过来,这将增加患者对这一重要成像技术的使用,最终促进国民健康和生活质量。技术摘要:光声成像提供与超声相似的深层组织成像,但具有增强的光学对比度和附加的功能和分子成像能力。然而,不像成熟的技术,如计算机断层扫描,没有标准化的性能测试方法或幻影存在的光声成像系统的评价。这里要研究的基本限制和科学问题是缺乏在宽范围的光波长和声频上同时模拟组织特性的材料。这使得研究者、仪器制造商和监管机构没有明确的策略来评估器械的安全性和有效性。该项目与美国食品药品监督管理局(FDA)建立了稳定的,生物相关的成像体模,具有良好的光学吸收/散射系数,声阻抗等,广泛模拟组织在广泛的光波长和声频。本研究的目的1是在光声成像过程中,开发具有生物相关异质形态和光散射伪影的体模。使用FDA提供的分光光度计和声脉冲传输设备,对体模材料的光学和声学特性进行严格表征。成像体模包含多层背景材料,其具有不同的光学和声学特性,旨在模拟天然组织(例如,乳房脂肪和腺体组织或肌肉和脂肪层)以及目标内含物。夹杂物具有不同大小的规则形状(圆柱体、球体)以及源自图像的曲折血管模拟结构。目标2使用这些体模建立测试方法,以评价三种不同成像系统中通量伪影对器械性能的影响。系统图像的均匀性和平面外的灵敏度进行评估,在机械扫描的探针超过现实的血管模仿夹杂物已知产生体积图像。套幻影包含夹杂物模仿血液吸收在几个氧饱和度水平,但具有不同的背景光学特性和层形态服务于参数研究的设备性能,在面对光谱着色文物。我们的三个光声成像系统的测量精度进行量化,以确定设备的鲁棒性,使用各种通量校正方法(扩散理论,蒙特卡罗模拟)。其成果是一个经过充分验证的组织模拟体模,以支持设备开发人员和通知监管决策,包括作为一个潜在的食品和药物管理局医疗器械开发工具的使用。该奖项反映了NSF的法定使命,并已被认为是值得通过使用基金会的智力价值和更广泛的影响审查标准进行评估的支持。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
3D-Bioprinted Phantom with Human Skin Phototypes for Biomedical Optics.
用于生物医学光学的具有人体皮肤光型的 3D 生物打印模型。
  • DOI:
    10.1002/adma.202206385
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yim,Wonjun;Zhou,Jiajing;Sasi,Lekshmi;Zhao,Jiayu;Yeung,Justin;Cheng,Yong;Jin,Zhicheng;Johnson,Wade;Xu,Ming;Palma-Chavez,Jorge;Fu,Lei;Qi,Baiyan;Retout,Maurice;Shah,NisargJ;Bae,Jinhye;Jokerst,JesseV
  • 通讯作者:
    Jokerst,JesseV
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jesse Jokerst其他文献

Jesse Jokerst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jesse Jokerst', 18)}}的其他基金

Tools to Control and Monitor Van der Waals Forces between Nanoparticles: Quantitative Insights on Biological, Environmental, and Fungal Cell Interactions.
控制和监测纳米颗粒之间范德华力的工具:对生物、环境和真菌细胞相互作用的定量见解。
  • 批准号:
    2335597
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Continuing Grant
Biomaterials built by biology: Mechanism and applications of hyperbranched fractal plasmonic structures
生物学构建的生物材料:超支化分形等离子体结构的机理和应用
  • 批准号:
    2242375
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
FDA Scholar Program: Blood-Mimicking Phantoms for Assessing Oximetry Performance of Photoacoustic Imaging Systems
FDA 学者计划:用于评估光声成像系统血氧饱和度性能的模拟血液模型
  • 批准号:
    2149602
  • 财政年份:
    2022
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
I-Corps: Development of a Periodontal Ultrasound/Photoacoustic Imaging Device
I-Corps:牙周超声/光声成像设备的开发
  • 批准号:
    2129540
  • 财政年份:
    2021
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
CAREER: Expandable sol-gel nanomaterials as therapeutic tools and imaging agents
职业:可膨胀溶胶-凝胶纳米材料作为治疗工具和成像剂
  • 批准号:
    1845683
  • 财政年份:
    2019
  • 资助金额:
    $ 20万
  • 项目类别:
    Continuing Grant
Advanced Polymeric Tissue-Mimicking Materials and Phantoms for Evaluation of Multispectral Photoacoustic Imaging Systems
用于评估多光谱光声成像系统的先进聚合物组织模拟材料和模型
  • 批准号:
    1842387
  • 财政年份:
    2018
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant

相似国自然基金

FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
  • 批准号:
    82373165
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
多维互质结构FDA雷达稀疏空时距自适应处理研究
  • 批准号:
    61771317
  • 批准年份:
    2017
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
  • 批准号:
    81573740
  • 批准年份:
    2015
  • 资助金额:
    63.0 万元
  • 项目类别:
    面上项目

相似海外基金

NSF/FDA SiR: Pulse Oximetry Measurement Errors Correlated with Patient Skin Pigmentation: Optical Mechanisms and Effect Multipliers
NSF/FDA SiR:与患者皮肤色素沉着相关的脉搏血氧饱和度测量误差:光学机制和效应乘数
  • 批准号:
    2229356
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF FDA/SiR: Development of eeDAP microscopy platform software, validation data, and statistical methods to assess performance of candidate Software as a Medical Device (SaMD)
NSF FDA/SiR:开发 eeDAP 显微镜平台软件、验证数据和统计方法,以评估候选软件作为医疗设备 (SaMD) 的性能
  • 批准号:
    2326317
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SiR: A Nonclinical Testing Tool for Wearable Photoplethysmography-Based Blood Pressure Monitoring Devices
NSF/FDA SiR:用于基于光电体积描记法的可穿戴血压监测设备的非临床测试工具
  • 批准号:
    2325722
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SiR: Validation and Standardization of Melanometry as a Quantitative Tool for Clinical Evaluation of Racial Disparities in Biophotonic Devices
NSF/FDA SiR:黑素测定法作为生物光子设备种族差异临床评估定量工具的验证和标准化
  • 批准号:
    2326485
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Robust, Reliable, and Trustworthy Regulatory Science Tool for Stroke Recovery Assessment using Hybrid Brain-Muscle Functional Coupling Analysis
NSF/FDA SIR:使用混合脑-肌肉功能耦合分析进行中风恢复评估的稳健、可靠且值得信赖的监管科学工具
  • 批准号:
    2229697
  • 财政年份:
    2022
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: 3D Human Stem Cell Cardiac Model for Cardiac Electrophysiology Medical Device Safety Assessment
NSF/FDA SIR:用于心脏电生理学医疗器械安全评估的 3D 人体干细胞心脏模型
  • 批准号:
    2129369
  • 财政年份:
    2022
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Towards the Establishment of a Validation Framework for Wearable Motion Analysis Systems: Development and Evaluation of an Open-Design Sync Platform
NSF/FDA SIR:建立可穿戴运动分析系统的验证框架:开放式设计同步平台的开发和评估
  • 批准号:
    2229538
  • 财政年份:
    2022
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Assessing the Photocytotoxicity and Photochemistry of New Emerging Fluorophores
NSF/FDA SIR:评估新兴荧光团的光细胞毒性和光化学
  • 批准号:
    2037815
  • 财政年份:
    2021
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Designing for Degradation: A framework for Predicting in vivo Degradation and Mechanical Property Changes in Degradable Polymers
NSF/FDA SIR:降解设计:预测可降解聚合物体内降解和机械性能变化的框架
  • 批准号:
    2129615
  • 财政年份:
    2021
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
NSF/FDA SIR: Numerical heart model for irreversible electroporation ablation
NSF/FDA SIR:不可逆电穿孔消融的数字心脏模型
  • 批准号:
    2129626
  • 财政年份:
    2021
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了